Autism affects about 1 in 36 children in the United States, according to the CDC. It's a condition that impacts how a person communicates, interacts, and experiences the world. But autism looks different in everyone. Some people need a lot of support, while others live independently. Some have strong language skills, others struggle to speak.
The problem is that current treatments are often one-size-fits-all. A therapy that helps one autistic person might not help another. This frustrates families and doctors alike.
For decades, scientists have suspected that autism involves an imbalance in brain activity. Think of the brain like a car: it needs the right balance of gas (excitation) and brakes (inhibition) to run smoothly. If there's too much gas or not enough brakes, things can go wrong. This is called the "excitation-inhibition" or E:I imbalance theory.
But proving this in humans has been hard. Brain scans are complex, and it's difficult to link them to real-world symptoms.
The Old Way vs. The New Way
Previously, researchers treated autism as one broad condition. They looked for a single cause or a single treatment that would work for everyone.
But here's the twist: this study suggests autism isn't one thing. It's two distinct types with opposite brain patterns. One type has too much excitation (too much gas), and the other has too little (not enough gas). This means we might need different treatments for each type.
To understand this, imagine the brain as a busy city. Neurons are like cars, and signals are like traffic lights. If the lights are too green (too much excitation), traffic jams happen. If they're too red (too much inhibition), nothing moves.
The researchers used computer models and animal tests to study two key brain signals:
1. Hurst exponent (H): This measures the "fractal" pattern of brain activity—like the roughness of a coastline. It tracks how excitable individual neurons are. 2. Gamma oscillations: These are fast brain waves that track the balance between excitation and inhibition.
Think of H as the "personality" of individual neurons (are they calm or excitable?), and gamma waves as the "traffic flow" of the whole brain network.
The team used computer simulations to model brain activity. They then tested these models in animals to confirm the patterns. Finally, they analyzed human EEG data (brain scans that measure electrical activity) from autistic individuals.
The study looked at brain signals from autistic people and compared them to their symptoms, like language skills and behavior.
The most important finding is that there are two autism neurosubtypes:
1. Type 1: High H (excitable neurons) and low gamma (low excitation-inhibition balance). These people often have more challenges with language and cognition. 2. Type 2: Low H (calm neurons) and high gamma (high excitation-inhibition balance). These people may have different co-occurring issues, like anxiety or ADHD.
In simple terms, one type has overexcited individual neurons but a quiet network, while the other has calm neurons but a noisy network.
This explains why autism looks so different in people. It also suggests that treatments should target the specific type.
But There's a Catch
This is where things get interesting. The study is still early. It's based on computer models and animal tests, and the human data is from a small group. We don't yet know if these subtypes are stable over time or if they respond differently to treatments.
This work is a step toward personalized medicine for autism. By identifying specific brain types, we can move beyond one-size-fits-all approaches. However, more research is needed to confirm these subtypes and test targeted therapies.
If you or a loved one is autistic, this research is promising but not yet actionable. It's not available now, and no treatments based on this are on the market. Talk to a doctor about current options, and keep an eye on future developments.
This doesn’t mean this treatment is available yet.
The study has several weaknesses. It's small, based on early-stage models, and the human EEG data is limited. We don't know if these subtypes are real or how they change over time. More research is needed.
Next, researchers will conduct larger human studies to confirm these subtypes. They'll also test if treatments tailored to each type work better than current options. This could take years, but it's a promising direction for autism research.